Pfizer’s future

BUSINESS

After years of falling revenue and profit, Pfizer has finally stabilized and is starting to rebound. The biggest U.S. drugmaker’s sales peaked in 2011 at $67.4 billion, long after its 2000 stock high of $45. Shares plunged to $12 by 2009, but are up...

Read latest Daily Freeman (Kingston, NY) online.

Online newspapers at PressDisplay. Newspapers from United States
Newspapers in English